Precision for Medicine is not your typical CRO. We are passionate about supporting professional growth and are proud to share extremely high CRA retention rates compared to industry averages.
CRAs join us, love their jobs, and stay because of the amazing people and enjoyable quality of life. Travel is reasonable and your work / life balance will benefit as a result. Most meaningfully - your voice will be heard. Working in a midsized CRO allows you to have influence and impact when it matters most with support from direct line management.
To support continued growth from our clients, we are hiring all levels of CRAs experienced in monitoring Lupus and / or Cardiology.
About you :
How you will spend your days as a CRA
You will monitor and own the progress of clinical studies at investigative sites and ensure that clinical studies are conducted, recorded, and reported per protocol, SOPs, ICH-GCP, and all applicable regulations and standards. You will coordinate all necessary activities required to set up and monitor a study (i.e., identify investigators; helping prepare regulatory submissions, conducting pre-study and initiation visits, etc.).
As a CRA, you will work with 2-3 protocols on average and support Project Managers with trials that are larger in scope. You will interact directly with clients, initiate payments, and participate in proposal activities, including development and client presentations.
Qualifications : CRA
About Precision for Medicine
Precision for Medicine is a precision medicine CRO. Precision’s uniquely integrated offerings enable the science of precision medicine by combining novel clinical trial designs, industry-leading operational and medical experts, advanced biomarker and data analytics solutions, and an unequivocal real passion for complex disease states.
Precision medicine is revolutionizing the attack on cancer. We strike tumors on a molecular level using biomarkers to link specific mutations to specific treatments. We combine deep science with deep data from advanced technological platforms, then layer on specialized expertise in the design and execution of targeted, adaptive clinical trials. Ultimately, we deliver robust insights that inform real-time decisions—and optimize the oncology development pathway.